Bitcoin traded around $75,000 after the US reported 165,000 new jobs in October, far exceeding expectations and lowering unemployment to 4.1%. This strong jobs data increased market expectations for a Federal Reserve rate hike in December, with a roughly 79% chance priced in. Key sectors like professional services, healthcare, and transportation showed notable job gains. Investors will watch the next employment report on December 4 ahead of the Fed meeting on December 9.
Bitcoin held near $75,000 following strong US jobs data in October. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 06, 2026 21:21 WIB: out of 50 major cryptocurrencies, 6 rose and 43 fell. Notable movers included SXP (Solar) down 46.27% to Rp37, ONE (Harmony) up 33.31% to Rp27 with 84% sell orders, and BAL (Balancer) up 11.14% to Rp16.297.
BriaCell Therapeutics and its subsidiary BriaPro presented positive preclinical data at the SITC 2026 Annual Meeting, highlighting their immunotherapy platforms Bria-OTS+ and BP-80. Bria-OTS+ showed broad immune activation and sustained cancer cell k...
IMUNON, Inc. presented new data from its Phase 2 OVATION 2 trial showing that IMNN-001, combined with chemotherapy, significantly enhances anti-tumor T-cell immune responses in advanced ovarian cancer patients. This immune activation correlates with ...
Canary Capital has launched the Canary Staked INJ ETF (INJC) on Nasdaq, providing investors exposure to INJ, the native token of the Injective blockchain. The ETF not only tracks INJ's price but also earns staking rewards from the network's proof-of-...
The Ozempic market, valued at $30.04 billion in 2026, is projected to grow to $113.95 billion by 2032, with a CAGR of 24.89%. This growth is fueled by increasing demand for diabetes and metabolic health treatments, wider adoption of GLP-1 therapies, ...
Minerva Neurosciences announced its third quarter 2026 financial results and business updates, highlighting progress in its Phase 3 trial of roluperidone, a drug targeting negative symptoms of schizophrenia. The ongoing C19 study aims to confirm prio...
